← Leaderboards
Esperanza Arias-Perez
Albert Einstein College Of Medicine
$1,707,556
Attributed
$1,707,556
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $378K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,707,556 · 2
By mechanism
R01$1,511,250 · 1
P30$196,306 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Britta Will$4,590,997
- Jeannette R. Mahoney$3,906,356
- Gil Atzmon$1,017,733
- Cristina Montagna$5,575,004
- Jan Vijg$2,376,698
Others in their field
Other Emerging Leaders on “Aging”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$64,693,871
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$25,556,733
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,272,240
- Abraham Aizer Brody · New York University School Of Medicine$23,963,022
Research focus
AgingFailureCancer TypeFunctional DisorderEffective InterventionExposure ToFunctional DisabilityFatty LiverDiabetes MellitusDiagnosisDietary FatsDisease ProgressionAutomobile DrivingCancer EtiologyGenetic EngineeringCatalystAutophagocytosisDeveloped CountriesCell PhysiologyCellsCell TransformationCell TypeCessation Of LifeGenetic Models
Grant awards (5)
Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging$196,306
P30 · FY2024 · AG · contact PI
Role of CMA failure in NASH progression to Hepatocellular Carcinoma$378,000
R01 · FY2023 · DK · contact PI
Role of CMA failure in NASH progression to Hepatocellular Carcinoma$378,000
R01 · FY2022 · DK · contact PI
Role of CMA failure in NASH progression to Hepatocellular Carcinoma$378,000
R01 · FY2021 · DK · contact PI
Role of CMA failure in NASH progression to Hepatocellular Carcinoma$377,250
R01 · FY2020 · DK · contact PI